NCT07109141Recruiting
Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland
Source: ClinicalTrials.gov · Last updated 7 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of the described project is to establish a multicenter, nationwide registry of atrial arrhythmia ablation procedures using the Pulsed Field Ablation (PFA) method. These procedures have only recently begun to be performed in several centers across Poland. With proper coordination of the registry, this will enable the consolidation of clinical data and the expansion of knowledge regarding the efficacy and safety of these procedures.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 31 Jul 2025
- Start date
- 1 Aug 2024
- Primary completion date
- 1 Jul 2030
- Lead sponsor
- Wroclaw Medical University
- Diseases
- Atrial fibrillation
- NCT number
- NCT07109141
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Aug 2024 to the primary completion date, 1 Jul 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Informed consent obtained from the participant
- Subject is undergoing ablation of an atrial arrhythmia using the PFA
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinical Department of Cardio, Jan Mikulicz Radecki University Hospital in Wroclaw Coordinator of this site? Confirm its status | Wroclaw | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.